• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPV E6/E7 mRNA检测对宫颈低度鳞状上皮内病变结局的预测价值

Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL.

作者信息

Cao Limei, He Ping, Yang Jun, Long Xin, Chen Yanqiu, Yan Li, Zhou Deping

机构信息

Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing 400000, China.

出版信息

Evid Based Complement Alternat Med. 2022 Aug 8;2022:8747919. doi: 10.1155/2022/8747919. eCollection 2022.

DOI:10.1155/2022/8747919
PMID:35978997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9377884/
Abstract

. To assess the predictive worth of HPV E6/E7 mRNA detection in the outcome of the cervical low-grade squamous intraepithelial lesion (LSIL). From September 2017 to early September 2019, patients screened for high-risk HPV positive or abnormal cervical liquid-based cytology were retrospectively analyzed and diagnosed with LSIL by cervical biopsy were recruited. The independent influencing factors of the regression of LSIL lesions after follow-up were analyzed, and the outcome of LSIL was calculated. The results of the initial colposcopy in this study were CIN I, CIN II/P16-negative, CIN II/P16-positive, and CIN III. At the time of re-examination, LSIL patients had three outcomes: regression, persistence, and progression. In the two follow-ups, 330 patients were finally included, including 276 CIN I patients (group A) and 54 CIN II/P16-negative patients (group B). The positive rates of HPV E6/E7 mRNA in each group were 66.67% and 70.37% for A and B, respectively. The total positive rate of E6/E7 mRNA was 67.27%, and there was no significant difference between the two groups ( > 0.05). After 1 year follow-up, whether HPV E6/E7 mRNA regressed or was negative was associated with the outcome of LSIL-related lesions ( < 0.05). The regression or negative rate of HPV E6/E7 mRNA was 1.57 times higher than the progression rate of HPV E6/E7 mRNA-positive diagnosis of LSIL lesions. Univariate logistic regression analysis showed that age at first sexual intercourse, HPV E6/E7 mRNA results, and lesion type were statistically significant ( < 0.05). Whether HPV E6/E7 mRNA was negative (OR = 2.420, =0.001) and age at first sexual intercourse ≥20 years (OR = 0.420, =0.002) were independent influencing factors associated with LSIL regression. Multivariate logistic analysis showed that age of first sexual intercourse ≥20 years (OR = 0.420, =0.002) and HPV E6/E7 mRNA-negative (OR = 2.420, =0.001) were independent factors associated with LSIL. HPV E6/E7 mRNA detection can be used for predicting the outcome of LSIL and has a good application value.

摘要

评估HPV E6/E7 mRNA检测对宫颈低度鳞状上皮内病变(LSIL)转归的预测价值。回顾性分析2017年9月至2019年9月初筛查高危型HPV阳性或宫颈液基细胞学异常且经宫颈活检确诊为LSIL的患者。分析随访后LSIL病变消退的独立影响因素,并计算LSIL的转归情况。本研究初始阴道镜检查结果为CIN I、CIN II/P16阴性、CIN II/P16阳性和CIN III。复查时,LSIL患者有三种转归情况:消退、持续和进展。在两次随访中,最终纳入330例患者,其中276例CIN I患者(A组)和54例CIN II/P16阴性患者(B组)。A、B两组HPV E6/E7 mRNA阳性率分别为66.67%和70.37%。E6/E7 mRNA总阳性率为67.27%,两组间差异无统计学意义(>0.05)。随访1年后,HPV E6/E7 mRNA是否消退或为阴性与LSIL相关病变的转归有关(<0.05)。HPV E6/E7 mRNA的消退或阴性率比HPV E6/E7 mRNA阳性诊断的LSIL病变进展率高1.57倍。单因素logistic回归分析显示,初次性交年龄、HPV E6/E7 mRNA结果和病变类型具有统计学意义(<0.05)。HPV E6/E7 mRNA是否为阴性(OR = 2.420,=0.001)和初次性交年龄≥20岁(OR = 0.420,=0.002)是与LSIL消退相关的独立影响因素。多因素logistic分析显示,初次性交年龄≥20岁(OR = 0.420,=0.002)和HPV E6/E7 mRNA阴性(OR = 2.420,=0.001)是与LSIL相关的独立因素。HPV E6/E7 mRNA检测可用于预测LSIL的转归,具有良好的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9377884/1a2a0845d529/ECAM2022-8747919.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9377884/7833e078143d/ECAM2022-8747919.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9377884/1a2a0845d529/ECAM2022-8747919.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9377884/7833e078143d/ECAM2022-8747919.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd14/9377884/1a2a0845d529/ECAM2022-8747919.002.jpg

相似文献

1
Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL.HPV E6/E7 mRNA检测对宫颈低度鳞状上皮内病变结局的预测价值
Evid Based Complement Alternat Med. 2022 Aug 8;2022:8747919. doi: 10.1155/2022/8747919. eCollection 2022.
2
[The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].[P16/ki67双标、HPV E6/E7 mRNA检测及其联合应用在低级别鳞状上皮内病变细胞学分流诊断中的价值]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Jan;36(1):63-68.
3
A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.一项对基线时 ASCUS 或 LSIL 巴氏涂片且 HPV E6/E7 mRNA 阳性的女性进行的前瞻性研究:3 年随访。
Epidemiol Infect. 2018 Apr;146(5):612-618. doi: 10.1017/S0950268818000250. Epub 2018 Feb 21.
4
Prognostic value of DNA and mRNA e6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2.人乳头瘤病毒DNA和mRNA的e6/e7在宫颈上皮内瘤变2级进展中的预后价值
Biomark Insights. 2014 Apr 13;9:15-22. doi: 10.4137/BMI.S14296. eCollection 2014.
5
Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.HPV E6/E7 mRNA 检测在原位杂交技术诊断宫颈上皮内病变中的准确性。
Diagn Pathol. 2021 Feb 19;16(1):13. doi: 10.1186/s13000-021-01072-9.
6
[The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].[宫颈上皮内瘤变I的自然史及p16(INK4a)蛋白作为宫颈上皮内瘤变I进展标志物的临床意义]
Zhonghua Fu Chan Ke Za Zhi. 2015 Mar;50(3):210-5.
7
Correlation analysis of human papillomavirus E6/E7 mRNA detection with diagnosis, prognosis and recurrence risk in patients with cervical epithelioma.人乳头瘤病毒E6/E7 mRNA检测与宫颈上皮瘤患者诊断、预后及复发风险的相关性分析
World J Clin Cases. 2024 Jul 16;12(20):4146-4153. doi: 10.12998/wjcc.v12.i20.4146.
8
[Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].[宫颈癌筛查中高危型人乳头瘤病毒E6/E7 mRNA与高危型人乳头瘤病毒DNA的对比研究]
Zhonghua Yi Xue Za Zhi. 2014 Nov 25;94(43):3432-5.
9
[The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].[人乳头瘤病毒E6/E7信使核糖核酸联合P16/ki67免疫细胞化学在意义不明确的非典型鳞状细胞(ASCUS)诊断中的作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Oct;34(10):937-941.
10
Preliminary study of the use of E6/E7mRNA detection in screening and triage management of HR-HPV infection during pregnancy.E6/E7mRNA检测在孕期高危型人乳头瘤病毒感染筛查及分流管理中的应用初步研究
Ann Transl Med. 2021 Sep;9(18):1428. doi: 10.21037/atm-21-4026.

引用本文的文献

1
Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.预测高级别宫颈前病变异常:个人因素、阴道微生物群、性传播感染和高危型人乳头瘤病毒的作用。
PLoS One. 2024 Nov 11;19(11):e0313004. doi: 10.1371/journal.pone.0313004. eCollection 2024.
2
Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL.撤回:人乳头瘤病毒E6/E7信使核糖核酸检测对宫颈低度鳞状上皮内病变转归的预测价值
Evid Based Complement Alternat Med. 2023 Sep 27;2023:9765428. doi: 10.1155/2023/9765428. eCollection 2023.

本文引用的文献

1
The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China.HPV E6/E7 mRNA检测在中国宫颈癌筛查中的潜在益处
Front Oncol. 2020 Oct 2;10:533253. doi: 10.3389/fonc.2020.533253. eCollection 2020.
2
HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review.用于检测高级别宫颈上皮内瘤变(CIN2+)的人乳头瘤病毒E6/E7信使核糖核酸检测:一项系统综述
Infect Agent Cancer. 2020 Feb 7;15:9. doi: 10.1186/s13027-020-0278-x. eCollection 2020.
3
Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
分别分析人乳头瘤病毒 E6 和 E7 信使 RNA 以预测宫颈癌进展。
PLoS One. 2018 Feb 21;13(2):e0193061. doi: 10.1371/journal.pone.0193061. eCollection 2018.
4
The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.HPV E6/E7 mRNA检测在对意义未明的不典型鳞状细胞或低级别鳞状上皮内病变巴氏涂片的女性进行分流中的临床应用:一项荟萃分析。
J Cancer Res Ther. 2017;13(4):613-620. doi: 10.4103/jcrt.JCRT_56_17.
5
Cervical cancer: screening, diagnosis and staging.宫颈癌:筛查、诊断与分期
J BUON. 2016 Mar-Apr;21(2):320-5.
6
Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.三种用于检测宫颈和阴道ThinPrep PreservCyt样本中高危型人乳头瘤病毒的商业系统的比较评估及其与活检结果的相关性
J Clin Microbiol. 2014 Oct;52(10):3763-8. doi: 10.1128/JCM.01928-14. Epub 2014 Aug 13.
7
Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.细胞内人乳头瘤病毒 E6、E7 mRNA 定量检测预测宫颈活检的 CIN2+病变的效能优于巴氏涂片细胞学检查,无论年龄大小。
Arch Pathol Lab Med. 2012 Aug;136(8):956-60. doi: 10.5858/arpa.2011-0180-OA.
8
Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.Aptima HPV E6/E7 mRNA 检测法与 Hybrid Capture 2 检测法相比,灵敏度相当,但在检测宫颈癌前病变和癌症方面的特异性更高。
J Clin Microbiol. 2011 Feb;49(2):557-64. doi: 10.1128/JCM.02147-10. Epub 2010 Dec 8.
9
Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia.特定类型的人乳头瘤病毒致癌基因信使 RNA 水平与宫颈上皮内瘤变的严重程度相关。
Int J Cancer. 2010 Aug 1;127(3):622-32. doi: 10.1002/ijc.25078.
10
Chapter 5: Updating the natural history of HPV and anogenital cancer.第5章:更新人乳头瘤病毒与肛门生殖器癌的自然史
Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51. doi: 10.1016/j.vaccine.2006.06.018. Epub 2006 Jun 23.